Integrilin |
Human |
eptifibatide |
eptifibatide |
EMEA/H/C/000230 |
GlaxoSmithKline (Ireland) Limited |
1999/07/01
|
Authorised |
Sustiva |
Human |
efavirenz |
efavirenz |
EMEA/H/C/000249 |
Bristol-Myers Squibb Pharma EEIG |
1999/05/28
|
Authorised |
Stocrin |
Human |
efavirenz |
efavirenz |
EMEA/H/C/000250 |
Merck Sharp & Dohme B.V. |
1999/05/28
|
Authorised |
Cotronak |
Human |
ribavirin |
Ribavirin |
EMEA/H/C/000247 |
Schering-Plough Europe |
1999/05/07
|
Withdrawn |
Rotashield |
Human |
rotavirus vaccine |
rotavirus serotype 1 reassortant, rotavirus serotype 2 reassortant, rotavirus serotype 3 rhesus, rotavirus serotype 4 reassortant |
EMEA/H/C/000192 |
Wyeth Lederle Vaccines S.A. |
1999/05/07
|
Withdrawn |
Procomvax |
Human |
haemophilus B conjugate (meningococcal protein conjugate) and hepatitis B (recombinant) vaccine |
polyribosylribitol phosphate from Haemophilus influenzae type b as PRP-OMPC, outer membrane protein complex of Neisseria meningitidis (outer membrane protein complex of the B11 strain of Neisseria meningitidis subgroup B), adsorbed hepatitis B surface ant |
EMEA/H/C/000231 |
Sanofi Pasteur MSD, SNC |
1999/05/07
|
Withdrawn |
Rebetol |
Human |
ribavirin |
Ribavirin |
EMEA/H/C/000246 |
Merck Sharp and Dohme B.V |
1999/05/06
|
Withdrawn |
ReFacto AF |
Human |
moroctocog alfa |
moroctocog alfa |
EMEA/H/C/000232 |
Pfizer Europe MA EEIG |
1999/04/13
|
Authorised |
Beromun |
Human |
tasonermin |
tasonermin |
EMEA/H/C/000206 |
Belpharma s.a. |
1999/04/12
|
Authorised |
Cetrotide |
Human |
cetrorelix |
cetrorelix (as acetate) |
EMEA/H/C/000233 |
Merck Europe B.V. |
1999/04/12
|
Authorised |
Regranex |
Human |
becaplermin |
becaplermin |
EMEA/H/C/000212 |
Janssen-Cilag International NV |
1999/03/29
|
Withdrawn |
Locatim (previously Serinucoli) |
Veterinary |
Locatim, oral solution for neonatal calves less than 12 hours of age |
Bovine concentrated lactoserum containing specific immunoglobulins G against E. coli F5 (K99) adhesin |
EMEA/V/C/000041 |
Biokema Anstalt |
1999/03/29
|
Authorised |
Econor |
Veterinary |
valnemulin |
valnemulin |
EMEA/V/C/000042 |
Elanco GmbH |
1999/03/12
|
Authorised |
Zerene |
Human |
zaleplon |
zaleplon |
EMEA/H/C/000228 |
Meda AB |
1999/03/12
|
Withdrawn |
Sonata |
Human |
zaleplon |
zaleplon |
EMEA/H/C/000227 |
Meda AB |
1999/03/12
|
Withdrawn |
Zenapax |
Human |
daclizumab |
daclizumab |
EMEA/H/C/000198 |
Roche Registration Ltd. |
1999/02/26
|
Withdrawn |
Infergen |
Human |
interferon alfacon-1 |
interferon alfacon-1 |
EMEA/H/C/000186 |
Astellas Pharma Europe B.V. |
1999/02/01
|
Withdrawn |
Emadine |
Human |
emedastine |
emedastine difumarate |
EMEA/H/C/000223 |
Immedica Pharma AB |
1999/01/27
|
Authorised |
Temodal |
Human |
temozolomide |
temozolomide |
EMEA/H/C/000229 |
Merck Sharp & Dohme B.V. |
1999/01/26
|
Authorised |
Triacelluvax |
Human |
diphtheria, tetanus and pertussis (acellular, component) vaccine (adsorbed) |
Diphtheria toxoid, haemagglutinin filamentous, pertussis pertactin, pertussis toxin, tetanus toxoid |
EMEA/H/C/000181 |
Chiron S.p.A. |
1999/01/11
|
Withdrawn |